Pre Next

[1] HUANGShaohui, HUANGZijian, SUNHaitao, et al. DiscussiononProfessorLVZhi-ping’sAcademicExperienceinTreatingLiverCirrhosisAfterHepatitisB [J]. Modern Traditional Chinese Medicine, 2021, (03): 68-72. [doi: 10.13424/j.cnki.mtcm.2021.03.014]

Copy

DiscussiononProfessorLVZhi-ping’sAcademicExperienceinTreatingLiverCirrhosisAfterHepatitisB

Modern Traditional Chinese Medicine[ISSN: 1006-6977/ CN: 61-1281/TN] Volumes & Issues: 2021 03 pagination: 68-72 Column: Publication date: 2021-05-20

Article number:: 1672-0571(2021)03-0068-05

Author(s):: HUANGShaohui¹; HUANGZijian²; SUNHaitao¹; GAOLei¹; ZHANGGuohua¹; ANHaiyan¹; PANGJie¹; HESongqi¹; 2; 1.SchoolofTraditionalChineseMedicine,SouthernMedicalUniversity,Guangzhou510515,China;2.IntegratedtraditionalChineseandWesternMedicineHospital,SouthernMedicalUniversity,Guangzhou510315,China

Keywords:: LivercirrhosisafterhepatitisB; Soothingtheliverandstrengtheningthespleen; Liverandspleendiseases; Detoxificationandremovingstasis; LVZhi-ping

ZTFLH:: R183.4

DOI:: 10.13424/j.cnki.mtcm.2021.03.014

Code:: A

Abstract:: ProfessorLVZhi-pingbelievesthattheetiologyandpathogenesisofpost-hepatiticcirrhosisarecharacterizedby“dampnessheattoxinandbloodstasis,liverdepressionandspleendeficiency”,andthepathologicalevolutionruleis“liverdiseasepassesontospleen,liverandspleenhavethesamedisease,themoredeficiencythedeficiencyis,themoreexcesstheexcessis”;ProfessorLVZhi-pingputforwardtheacademicpointofviewthat“treatingliverandgallbladderdiseasesshouldsoothingliverandstrengtheningspleen,regulatingtheQiactivity,andthetreatmentprincipleis“liverandgallbladdersoothing,spleentonifying,detoxificationandstasisremovingthroughthewholeprocessoftreatment”.ItsclinicalexperienceinthediagnosisandtreatmentoflivercirrhosisafterhepatitisBisreflectedinthemedicalrecordsofthedisease,andhasachievedgoodresults.

References:

[1]崔华复,徐朝峰.慢性乙型肝炎隐证型临床研究[J].中国医药学报,2002,(9):537-538.
[2]贺松其,吕志平,张绪富.保肝宁治疗慢性乙型肝炎肝纤维化 128例疗效观察 [J].新中医,2008,40(4):24-25.
[3]王贵强,王福生,成军,等.慢性乙型肝炎防治指南2015年版)[J].实用肝脏病杂志,2016,19(3):389-400.
[4]OttJJ,StevensGA,GroegerJ,etal.GlobalepidemiologyofhepatitisBvirusinfection:newestimatesofage-specificHBsAgseroprevalenceandendemicity[J].Vaccine,2012,30(12):2212-2219.
[5]LozanoR,NaghaviM,ForemanK,etal.Globalandregionalmortalityfrom235causesofdethfor20agegroupsin1990and2010:asystematicanalysisfortheGlobalBurdenofDiseaseStudy2010[J].Lancet,2012,380(9859):2095-2128.
[6]慢性乙型肝炎中医诊疗指南(2018年版)[J].中西医结合肝病杂志,2019,29(1):97-102.
[7]唐芸,王洪琦.岭南湿热证候理论源流探究[J].广西中医药,2009,32(2):5455.
[8]蒋亚君,阮清发.康氏肝病学术流派从湿热疫毒辨治慢性乙型病毒性肝炎肝纤维化经验探要[J].上海中医药杂志,2019,53(9):36-37.
[9]李志群,张丰,祝扬,等.慢性乙型肝炎肝脏微循环障碍发生发展机制的研究[J].实用肝脏病杂志,2010,13(2):104-106.
[10]吕志平,刘承才.微循环方法在中医诊法研究中的应用[J].辽宁中医杂志,1993,(3):43-47.
[11]梁治学,王晓萍,周语平.肝纤维化的中医病因病机研究概况[J].甘肃中医,2006,19(4):43-45.
[12]张国梁,李艳.慢性乙型肝炎中医病因病机研究概述[J].中医药临床杂志,2012,24(7):687-689.
[13]贺松其,吕志平.慢性乙型肝炎辨治规律及用药原则探讨[J].福建中医药,2002,33(6):43-44.
[14]贺松其,张绪富,蔡红兵.吕志平教授辨治慢性肝炎肝纤维化经验介绍[J].新中医,2005,37(3):16-17.
[15]陈瑞年,卢秉久.中医关于慢性乙肝病机演变及证治探讨[J].辽宁中医杂志,2019,46(6):1181-1183.
[16]方妍.中医“肝主疏泄”理论源流与发展的研究[D].长春:长春中医药大学,2019.

Memo

基金项目：第四批全国中医临床优秀人才研修项目（国中医人教发【２０１７】２４号）；全国名老中医药专家传承工作室项目（国中医药人教发【２０１６】４２号）

Last Update: 2021-06-08